- Home
- PVLA vs IMOS Comparison
PVLA vs IMOS Comparison
Compare PVLA & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PVLA | IMOS |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | PVLA | IMOS |
|---|---|---|
| Price | $133.00 | $43.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $154.59 | N/A |
| AVG Volume (30 Days) | ★ 355.7K | 37.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.37 |
| Revenue Next Year | N/A | $11.46 |
| P/E Ratio | ★ N/A | $158.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.23 | $12.78 |
| 52 Week High | $151.18 | $45.43 |
Technical Indicators
Market Signals| Indicator | PVLA | IMOS |
|---|---|---|
| Relative Strength Index (RSI) | 68.31 | 66.33 |
| Support Level | $85.53 | $19.16 |
| Resistance Level | N/A | $45.43 |
| Average True Range (ATR) | 8.58 | 1.72 |
| MACD | 6.87 | 1.01 |
| Stochastic Oscillator | 73.74 | 86.54 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.